UNSPSC 41181944: Immunomagnetic circulating cancer cell selection and enumeration system tests

In this classification, a Immunomagnetic circulating cancer cell selection and enumeration system tumor associated antigen immunological test system that consists of the reagents used to identify by immunochemical techniques Immunomagnetic circulating cancer cell selection and enumeration system based tumors. US FDA regulates Immunomagnetic circulating cancer cell selection and enumeration system under 21 CFR 866.6020 and under FDA product code NQI.

UNSPSC 41181944 Immunomagnetic circulating cancer cell selection and enumeration system tests (Commodity) does not align with the recent state and local procurement activity tagged under this code. The source contains no solicitations for cancer cell selection systems, immunomagnetic testing, or enumeration services. Instead, the opportunities span laboratory equipment repair and maintenance, materials testing and inspection services, water treatment infrastructure, electric utility metering systems, and university research equipment — work that does not fall within the stated scope of this Commodity code.

The mismatch between the code name and the actual solicitations suggests either systematic miscoding by issuing bodies or that the code has drifted from active purchasing use. State and local procurement systems sometimes apply codes based on partial keyword matches or legacy classification habits rather than precise alignment. If this code is relevant to your business, verify the actual scope through direct contact with individual procuring jurisdictions rather than relying on code-level aggregation. No actionable activity exists under this code in the current opportunity set.